Background <p>According to PI-RADS v2.1, peripheral PI-RADS 3 lesions are upgraded to PI-RADS 4 if dynamic contrast-enhanced MRI is positive (3+1 lesions), however those lesions are radiologically challenging. We aimed to define criteria by expert consensus and test applicability by other radiologists for sPC prediction of PI-RADS 3+1 lesions and determine their value in integrated regression models.</p> Methods <p>From consecutive 3 Tesla MR examinations performed between 08/2016 to 12/2018 we identified 85 MRI examinations from 83 patients with a total of 94 PI-RADS 3+1 lesions in the official clinical report. Lesions were retrospectively assessed by expert consensus with construction of a newly devised feature catalogue which was utilized subsequently by two additional radiologists specialized in prostate MRI for independent lesion assessment. With reference to extended fused targeted and systematic TRUS/MRI-biopsy histopathological correlation, relevant catalogue features were identified by univariate analysis and put into context to typically available clinical features and automated AI image assessment utilizing lasso-penalized logistic regression models, also focusing on the contribution of DCE imaging (feature-based, bi- and multiparametric AI-enhanced and solely bi- and multiparametric AI-driven).</p> Results <p>The feature catalog enabled image-based lesional risk stratification for all readers. Expert consensus provided 3 significant features in univariate analysis (adj. p-value &lt;0.05; most relevant feature T2w configuration: “irregular/microlobulated/spiculated”, OR 9.0 (95%CI 2.3-44.3); adj. p-value: 0.016). These remained after lasso penalized regression based feature reduction, while the only selected clinical feature was prostate volume (OR&lt;1), enabling nomogram construction. While DCE-derived consensus features did not enhance model performance (bootstrapped AUC), there was a trend for increased performance by including multiparametric AI, but not biparametric AI into models, both for combined and AI-only models.</p> Conclusions <p>PI-RADS 3+1 lesions can be risk-stratified using lexicon terms and a key feature nomogram. AI potentially benefits more from DCE imaging than experienced prostate radiologists.</p> Clinical trial number <p>Not applicable.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Improving risk stratification of PI-RADS 3 + 1 lesions of the peripheral zone: expert lexicon of terms, multi-reader performance and contribution of artificial intelligence

  • Philip A. Glemser,
  • Nils Netzer,
  • Christian H. Ziener,
  • Markus Wilhelm,
  • Thomas Hielscher,
  • Kevin Sun Zhang,
  • Magdalena Görtz,
  • Viktoria Schütz,
  • Albrecht Stenzinger,
  • Markus Hohenfellner,
  • Heinz-Peter Schlemmer,
  • David Bonekamp

摘要

Background

According to PI-RADS v2.1, peripheral PI-RADS 3 lesions are upgraded to PI-RADS 4 if dynamic contrast-enhanced MRI is positive (3+1 lesions), however those lesions are radiologically challenging. We aimed to define criteria by expert consensus and test applicability by other radiologists for sPC prediction of PI-RADS 3+1 lesions and determine their value in integrated regression models.

Methods

From consecutive 3 Tesla MR examinations performed between 08/2016 to 12/2018 we identified 85 MRI examinations from 83 patients with a total of 94 PI-RADS 3+1 lesions in the official clinical report. Lesions were retrospectively assessed by expert consensus with construction of a newly devised feature catalogue which was utilized subsequently by two additional radiologists specialized in prostate MRI for independent lesion assessment. With reference to extended fused targeted and systematic TRUS/MRI-biopsy histopathological correlation, relevant catalogue features were identified by univariate analysis and put into context to typically available clinical features and automated AI image assessment utilizing lasso-penalized logistic regression models, also focusing on the contribution of DCE imaging (feature-based, bi- and multiparametric AI-enhanced and solely bi- and multiparametric AI-driven).

Results

The feature catalog enabled image-based lesional risk stratification for all readers. Expert consensus provided 3 significant features in univariate analysis (adj. p-value <0.05; most relevant feature T2w configuration: “irregular/microlobulated/spiculated”, OR 9.0 (95%CI 2.3-44.3); adj. p-value: 0.016). These remained after lasso penalized regression based feature reduction, while the only selected clinical feature was prostate volume (OR<1), enabling nomogram construction. While DCE-derived consensus features did not enhance model performance (bootstrapped AUC), there was a trend for increased performance by including multiparametric AI, but not biparametric AI into models, both for combined and AI-only models.

Conclusions

PI-RADS 3+1 lesions can be risk-stratified using lexicon terms and a key feature nomogram. AI potentially benefits more from DCE imaging than experienced prostate radiologists.

Clinical trial number

Not applicable.